Please use this identifier to cite or link to this item: http://adhlui.com.ui.edu.ng/jspui/handle/123456789/3053
Full metadata record
DC FieldValueLanguage
dc.contributor.authorADELUSI, B-
dc.contributor.authorOSUNKOYA, B O-
dc.contributor.authorFABIYI, A-
dc.date.accessioned2024-10-09T10:04:57Z-
dc.date.available2024-10-09T10:04:57Z-
dc.date.issued1976-
dc.identifier.citationAfr. J. Med. med. Sci. (1976)5, 297-301en_US
dc.identifier.issn1116-4077-
dc.identifier.urihttp://adhlui.com.ui.edu.ng/jspui/handle/123456789/3053-
dc.descriptionARTICLEen_US
dc.description.abstractVarious studies have associated Herpes Type-2 (HT-2) virus with carcinoma of the cervix, especially the squamous cell type. In the present study, prevalence of HT-2 virus antibodies was found to be significantly higher in patients with squamous cell carcinoma of the cervix than in cases with squamous cell carcinoma of sites other than the cervix, and other pelvic and extra pelvic malignancies (/'< 0 001). It was concluded that no association could be found between Herpes Type-2 virus and malignancies of sites other than the cervixen_US
dc.description.sponsorshipCOLLEGE OF MEDICINE,UNIVERSITY OF IBADANen_US
dc.language.isoenen_US
dc.publisherCOLLEGE OF MEDICINEen_US
dc.subjectsquamousen_US
dc.subjectcervixen_US
dc.subjectherpesen_US
dc.subjectextrapelvicen_US
dc.titleHerpes type-2 virus antibody status in groups of patients with neoplasm in Ibadanen_US
dc.typeArticleen_US
Appears in Collections:African Journal of Medicine and Medical Sciences

Files in This Item:
File Description SizeFormat 
Adelusi et al_Herpes_1976.pdfARTICLE5.78 MBAdobe PDFView/Open


Items in COMUI (ADHL) are protected by copyright, with all rights reserved, unless otherwise indicated.